✳flâneur — a map of the web's best reading
At last, a pill that can prevent COVID after exposure to infected people
nature.com · 457 words · saved by 1 readers
Drug arrives years after pandemic’s peak, but could still offer protection to vulnerable populations.
Email Bluesky Facebook LinkedIn Reddit Whatsapp X Access through your institution Buy or subscribe An antiviral pill has, for the first time, been shown to prevent COVID-19 in people exposed to the SARS-CoV-2 virus at home, according to trial results published today in the New England Journal of Medicine 1 . Access options Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $
Explore this link on the map →related reading
- How antiviral pill molnupiravir shot ahead in the COVID drug huntnature.com
- COVID-19 drug discovery and treatment options | Nature Reviews Microbiologynature.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Interceptinterceptfund.com
- A lucky few seem 'resistant' to Covid-19. Scientists ask why | STATstatnews.com
- Scientists make breakthrough towards ‘universal’ antiviral drugsgavi.org
- Nature's drug database - The Works in Progress Newsletterworksinprogress.news
- Inevitable Outbreaks: How to Stop an Age of Spillovers From Becoming an Age of Pandemicsforeignaffairs.com
- What most surprised experts about the Covid pandemic | STATstatnews.com
- Checking your browser - reCAPTCHAncbi.nlm.nih.gov
- Making Vaccine — LessWronglesswrong.com
- The Year the Pandemic “Ended” (Part III) – The New Inquirythenewinquiry.com